American Oncology Network Inc. $(AON)$ has announced that Dr. Taral Patel, a Board-certified medical oncologist from the Zangmeister Cancer Center, presented new research at the IASLC World Conference on Lung Cancer in Barcelona. The study, titled "Assessment of molecular testing in stage IV non-small cell lung cancer patients across American Oncology Network," evaluates AON's quality initiatives in collaboration with Integra Connect PrecisionQ to enhance testing for stage IV lung cancer patients. The findings were shared in a poster presentation at the conference, underscoring the research's relevance to the field. The study highlights AON's commitment to advancing lung cancer care and contributing to the broader scientific community.